Comparative Pharmacology
Head-to-head clinical analysis: HYDRODIURIL versus NATURETIN 2 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDRODIURIL versus NATURETIN 2 5.
HYDRODIURIL vs NATURETIN-2.5
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits sodium-chloride symporter in the distal convoluted tubule of the kidney, increasing excretion of sodium and water, reducing plasma volume and cardiac output.
Bendroflumethiazide is a thiazide diuretic that inhibits the sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, reducing sodium and chloride reabsorption and promoting diuresis.
25-100 mg orally once daily. For hypertension: 12.5-25 mg once daily.
Hypertension: 2.5 mg orally once daily; may increase to 5 mg daily if needed. Edema: 2.5 to 10 mg orally once daily.
None Documented
None Documented
Terminal elimination half-life is approximately 5.6–14.8 hours (mean ~10 hours); clinically, duration of diuresis correlates with half-life, allowing once or twice daily dosing.
Terminal elimination half-life: 6-9 hours; prolonged in renal impairment and in elderly patients.
Renal: approximately 95% eliminated unchanged in urine via glomerular filtration and tubular secretion; biliary/fecal: <5%.
Renal excretion: approximately 95% as unchanged drug; biliary/fecal: <5%.
Category C
Category C
Thiazide Diuretic
Thiazide Diuretic